Activists Say New HIV Drug Price Encouraging A coalition of United States HIV/AIDS treatment activists has given thumbs up to what it sees as an encouraging trend in HIV drug costs, based on the price announced for the recently approved protease inhibitor Prezista? (darunavir).
June 23, 2006
Protease Inhibitor Prezista Approved The U.S. Food and Drug Administration (FDA) announced on June 23 that it has approved Prezista? (darunavir), a new drug for adults whose infection with HIV is no longer responding to treatment with other anti-HIV drugs.
Got Milk? Don't Let Dairy Get You Down Chronic diarrhea remains a common problem for people living with HIV, and many doctors advise restricting the intake of dairy products to prevent or reverse symptoms. But a recent Canadian study has concluded that moderate dairy ingestion does not worsen diarrhea in HIV-positive people with chronic diarrhea, regardless of their lactose-tolerance status.
Aptivus Study Halted A clinical trial of Aptivus® (tipranavir) has been discontinued due to limited effectiveness, along with earlier concerns of liver toxicities, in treatment-naive study volunteers receiving the drug.
HIV Vaccines: They're Not Perfect But... Even if an HIV vaccine is incapable of preventing infection, new studies suggest that it may confer a significant survival advantage for those who are infected with the virus.
June 05, 2006
HIV/AIDS Treatment: Three Million Years of Life Saved in U.S. Increasingly effective therapy to manage HIV infection and to prevent and treat AIDS-related complications has provided 3 million years of extended life to Americans with HIV since 1989, according to a new report published in the June 1st issue of the Journal of Infectious Diseases.
June 01, 2006
Making the Link: Chimps Believed Source of HIV Twenty-five years after the first AIDS cases were officiallydocumented, a new report published in Science indicatesthat researchers have isolated the source of HIV responsiblefor the global pandemic: a colony of chimpanzees insouthern Cameroon.
More Treatment News
Have news about HIV? Send press releases, news tips and other announcements to firstname.lastname@example.org.